Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$1.50
-6.3%		$1.49
$1.25
▼
$3.11
$10.60M0.3118,385 shs29,452 shs
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
$25.63
+0.4%		$25.63
$22.22
▼
$26.13
$8.20M-1.061,379 shs9,200 shs
Premier Health of America Inc. stock logo
PHA
Premier Health of America
C$0.01
C$0.01
C$0.01
▼
C$0.07
C$278K-0.04141564,571 shs370,300 shs
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
$0.00
$0.97
▼
$4.56
$16.16M1.38197,338 shs57,700 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-6.25%+0.67%+3.45%+2.04%-41.86%
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00%0.00%0.00%0.00%0.00%
Premier Health of America Inc. stock logo
PHA
Premier Health of America
0.00%0.00%0.00%-66.67%-87.50%
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$1.50
-6.3%		$1.49
$1.25
▼
$3.11
$10.60M0.3118,385 shs29,452 shs
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
$25.63
+0.4%		$25.63
$22.22
▼
$26.13
$8.20M-1.061,379 shs9,200 shs
Premier Health of America Inc. stock logo
PHA
Premier Health of America
C$0.01
C$0.01
C$0.01
▼
C$0.07
C$278K-0.04141564,571 shs370,300 shs
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
$0.00
$0.97
▼
$4.56
$16.16M1.38197,338 shs57,700 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-6.25%+0.67%+3.45%+2.04%-41.86%
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00%0.00%0.00%0.00%0.00%
Premier Health of America Inc. stock logo
PHA
Premier Health of America
0.00%0.00%0.00%-66.67%-87.50%
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
0.00
N/AN/AN/A
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00
N/AN/AN/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
0.00
N/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$28.08M0.35$0.61 per share2.44$4.23 per share0.35
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/AN/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
C$87.67M0.00N/AN/AC($0.25) per share-0.02
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/A$4.95 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-$1.55M$0.60N/AN/AN/A-5.83%-6.41%-3.13%N/A
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/A28.81N/AN/AN/AN/AN/AN/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
-C$12.50M-C$0.28N/AN/AN/A-17.94%202.02%0.89%N/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
-$14.27M-$1.21N/AN/AN/AN/A-26.14%-22.74%N/A

Latest PHA, SYN, AMS, and CSH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-$0.02-$0.07-$0.05-$0.07$7.56 million$8.43 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
N/AN/AN/AN/AN/A
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/A0.00%N/AN/AN/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
N/AN/AN/AN/AN/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
N/A
0.77
0.77
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
-328.55
0.34
N/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
N/A
4.14
4.14

Institutional Ownership

CompanyInstitutional Ownership
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
23.16%
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
N/A
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
74.38%

Insider Ownership

CompanyInsider Ownership
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
25.80%
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/A
Premier Health of America Inc. stock logo
PHA
Premier Health of America
52.10%
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
2.15%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
106.62 million4.92 millionNot Optionable
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/A320,000N/ANot Optionable
Premier Health of America Inc. stock logo
PHA
Premier Health of America
N/A55.51 millionN/ANot Optionable
Synthetic Biologics, Inc. stock logo
SYN
Synthetic Biologics
1615.84 million15.50 millionNot Optionable

Recent News About These Companies

Isto Biologics Strengthens its Bone Graft Substitutes Platform with the Acquisition of NovaBone
August 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/isto-biologics-strengthens-bone-graft-144000179.html
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
July 21, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vivex-biologics-launches-via-linx-a-novel-self-assembling-synthetic-peptide-matrix-expanding-its-portfolio-of-advanced-wound-care-solutions-1036345718
Computational design drives new generation of synthetic promoters
March 27, 2026  |  drugtargetreview.comD
Gene Synthesis Market Comprehensive Industry Analysis, Trends, and Future Outlook
February 25, 2026  |  pharmiweb.comP
6 ways biologics is advancing in spine
February 19, 2026  |  beckersspine.comB
Stopping Biologics Before Surgery May Raise Flare Risk in RA
January 27, 2026  |  rheumatologyadvisor.comR
Study Shows NanoFuse(R) Superiority: Why Bioactive Glass-DBM Composites Outperform DBM and Bioactive Glass Alone
January 26, 2026  |  marketwatch.comhttps://www.marketwatch.com/press-release/study-shows-nanofuse-r-superiority-why-bioactive-glass-dbm-composites-outperform-dbm-and-bioactive-glass-alone-9d78ab86
MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix™
January 15, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/mtf-biologics-kolosis-bio-launch-180500270.html
MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix(TM)
January 15, 2026  |  marketwatch.comhttps://www.marketwatch.com/press-release/mtf-biologics-and-kolosis-bio-launch-new-solution-for-orthopedic-and-spinal-surgeries-summit-matrix-tm-130fb300
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
January 13, 2026  |  pharmiweb.comP
4 orthobiologics updates
December 18, 2025  |  beckersspine.comB
Exposure to Some DMARDs in Fathers-to-Be Tied to Birth Risks
December 2, 2025  |  medscape.comM
Relapse in Juvenile Idiopathic Arthritis After Stopping DMARDs: Key Factors Found
December 1, 2025  |  medscape.comM
Constructive Bio and RxCelerate partner to develop biologic therapeutic candidates
November 19, 2025  |  businessweekly.co.ukB
RA Onset Age Doesn’t Affect Non-TNF Agents’ Infection Risk
October 29, 2025  |  medscape.comM
Aurora Spine Launches New Biologics Portfolio
October 28, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/aurora-spine-launches-new-biologics-portfolio-1035434970
Wound Care Biologics Market Size Worth USD 11.22 Billion by 2034
October 27, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/wound-care-biologics-market-size-071500629.html
Study assesses SI joint outcomes between surgeons, pain physicians
October 21, 2025  |  beckersspine.comB
Active Pharmaceutical Ingredients (API) Market worth $198.39 billion by 2030 with 6.6% CAGR | MarketsandMarkets™
October 15, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/active-pharmaceutical-ingredients-api-market-143000744.html
Rheumatoid Arthritis Linked to Elevated Pneumonia Risk, Especially in Seropositive Disease
October 1, 2025  |  ajmc.comA

Media Sentiment Over Time

Top Headlines

View All Headlines
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
Broadcom logo on a silicon wafer with circuit boards, fiber optic cables, and a network switch in a data center.
Broadcom May Be the Biggest Winner From Alphabet's Earnings
By Leo Miller | July 26, 2026
Illustration of the Google "G" logo surrounded by colorful light streaks and digital data effects.
Alphabet Crushed Earnings, But One Number Spooked the Market
By Ryan Hasson | July 23, 2026
Smartphone displaying the Uber logo stands on a marble ledge with keys, overlooking a city skyline.
Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
By Jeffrey Neal Johnson | July 16, 2026
Illuminated onsemi logo on glass block set against a semiconductor wafer and circuit board background.
The AI Chip Stock Making a Quiet Move Toward Dominance
By Thomas Hughes | August 4, 2026
American Shared Hospital Services stock logo

American Shared Hospital Services NYSEAMERICAN:AMS

$1.50 -0.10 (-6.25%)
Closing price 08/14/2026 04:10 PM Eastern
Extended Trading
$1.51 +0.01 (+0.67%)
As of 08/14/2026 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo

Morgan Creek-Exos Active SPAC Arbitrage ETF NYSEARCA:CSH

$25.63 +0.09 (+0.35%)
As of 04/11/2023

The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is an exchange-traded fund that mostly invests in extended market equity. The fund is actively managed to provide exposure to US-listed pre-combination special purpose acquisition companies (SPACs) through the use of common stock, warrants and rights. Positions will generally be in small- and mid-cap companies. CSH was launched on Feb 1, 2022 and is managed by Morgan Creek.

Premier Health of America stock logo

Premier Health of America CVE:PHA

C$0.0050 0.00 (0.00%)
As of 06/23/2026

Premier Health of America Inc., together with its subsidiaries, engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada. It operates in two segments, Per Diem and Travel Nurse. The company provides temporary or permanent resources, including registered nurses, registered practical nurses, registered therapists, and personal support workers for public and private hospitals, medical clinics, and retirement homes. It also offers health consulting, nursing, and healthcare services in remote communities, as well as provides nursing and assistance services in remote regions; and Code Bleu, an agency to employ staff nurses. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company is headquartered in Blainville, Canada.

Synthetic Biologics stock logo

Synthetic Biologics NYSEAMERICAN:SYN

Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11 to treat cancer. It has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Synthetic Biologics, Inc. is headquartered in Rockville, Maryland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas